Abstract
The use of radioactive 2-methylthio-ADP (2MeS-ADP) to study ADP receptors on platelets was first developed by MacFarlane et al. (1) in 1983. However, this technique may not have initially been pursued by many groups because of the relative paucity of studies into platelet ADP receptors and the absence of a commercially available radiolabeled ligand. From 1992 to 1994, a few papers described the use of 2MeS-ADP to demonstrate the antagonistic activity of clopidogrel on the platelet ADP receptor (2–4) and the presence of ADP receptors on megakaryocytoblastic cells (5). Since these initial reports, several groups have published studies describing the binding characteristics of 2MeS-ADP on platelets (6,7). Two different teams provided evidence for a defect of ADP receptor numbers in platelets from patients with a low sensitivity to ADP (8,9). Consequently, a variety of antiplatelet compounds have been evaluated as antagonists on platelet ADP receptors (10–13). A recent study has demonstrated the ability of P2Y12 to bind 2MeS-ADP, supporting its identity as the previously named P2TAC or low-affinity platelet ADP receptor (14).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
MacFarlane, D. E., Srivastava, P. C., and Mills, D. C. B. (1983) 2-Methylthioadenosine [γ-32P] diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J. Clin. Invest. 71, 420–428.
Mills, D. C. B., Puri, R., Hu, C.-J., Minniti, C., Grana, G., Freedman, M. D., Colman, R. F., and Colman, R. W. (1992) Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arteriosclerosis Thrombosis 12, 430–436.
Savi, P., Laplace, M. C., Maffrand, J. P., and Herbert, J. M. (1994) Binding of [3H]-2-methylthio ADP to rat platelets: effect of clopidogrel and ticlopidine. J. Pharm. Exp. Ther. 269, 772–777.
Savi, P., Laplace, M. C., and Herbert, J. M. (1994) Evidence for the existence of two different ADP-binding sites on rat platelets. Thromb. Res. 76, 157–169.
Savi, P., Troussard, A. and Herbert, J. M. (1994) Characterization of specific binding sites for [3H]-2-MeS-ADP on megakaryocytoblastic cell lines in culture. Biochem. Pharmacol. 48, 83–86.
Gachet, C., Cattaneo, M., Ohlmann, P., Hechler, B., Lecchi, A., Chevalier, J., et al. (1995) Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Brit. J. Haematol. 91, 434–444.
Jantzen, H. M., Gousset, L., Bhaskar, V., Vincent, D., Tai, A., Reynolds, E. E., et al. (1999) Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb. Haemost. 81, 111–117.
Nurden, P., Savi, P., Heilmann, E., Bihour, C., Herbert, J. M., Maffrand, J. P., et al. (1995) An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J. Clin. Invest. 95, 1612–1622.
Cattaneo, M., Lombardi, R., Zighetti, M. L., Gachet, C., Ohlmann, P., Cazenave, J. P., et al. (1997) Deficiency of 33P-2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Thromb. Haemost. 77, 986–990.
Sugidachi, A., Asai, F., Yoneda, K., Iwamura, R., Ogawa, T., Otsuguro, K., et al. (2001) Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type Gi-linked P2T antagonist, CS-747. Brit. J. Pharmacol. 132, 47–54.
Baurand, A., Raboisson, P., Freund, M., Leon, C., Cazenave, J. P., Bourguignon, J. J., et al. (2001) Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur. J. Pharmacol. 412, 213–221.
Scarborough, R. M., Laibelman, A. M., Clizbe, L. A., Fretto, L. J., Conley, P. B., Reynolds, E. E., et al. (2001) Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y12). Bioorg. Med. Chem. Lett. 11, 1805–1808.
Savi, P., Pereillo, J. M., Uzabiaga, M. F., Combalbert, J., Picard, C, Maffrand, J. P., et al. (2000) Identification and biological activity of the active metabolite of clopidogrel. Thromb. Haemost. 84, 891–896.
Savi, P., Labouret, C., Delesque, N., Guette, F., Lupker, J., and Herbert, J. M. (2001) P2Y12, a new platelet ADP receptor, target of clopidogrel. Biochem. Biophys. Res. Commun. 283, 379–383.
Hechler, B., Vigne, P., Léon, C., Breittmayer, J. P., Gachet, C., and Frelin, C. (1998) ATP derivatives are antagonists of the P2Y1 receptor: Similarities to the platelet ADP receptor. Mol. Pharmacol. 59, 727–733.
Munson, P. J. and Rodbard, D. (1980) Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107, 220–239.
Scatchard, G. (1949) The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51, 660–672.
Cheng, Y. C. and Prusoff, W. H. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitors which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108.
Savi, P., Beauverger, P., Labouret, C., Delfaud, M., Salel, V., Kaghad, M., et al. (1998) Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett. 422, 291–295.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Savi, P., Herbert, JM. (2004). Use of Radiolabeled 2-Methylthio-ADP to Study P2Y Receptors on Platelets and Cell Lines. In: Gibbins, J.M., Mahaut-Smith, M.P. (eds) Platelets and Megakaryocytes. Methods in Molecular Biology™, vol 273. Humana Press. https://doi.org/10.1385/1-59259-783-1:115
Download citation
DOI: https://doi.org/10.1385/1-59259-783-1:115
Publisher Name: Humana Press
Print ISBN: 978-1-58829-011-3
Online ISBN: 978-1-59259-783-3
eBook Packages: Springer Protocols